Rhumbline Advisers Boosts Holdings in Molina Healthcare, Inc $MOH

Rhumbline Advisers increased its stake in shares of Molina Healthcare, Inc (NYSE:MOHFree Report) by 4.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 147,642 shares of the company’s stock after acquiring an additional 6,096 shares during the quarter. Rhumbline Advisers owned about 0.27% of Molina Healthcare worth $28,253,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of MOH. First Horizon Advisors Inc. lifted its holdings in shares of Molina Healthcare by 2,140.0% in the 2nd quarter. First Horizon Advisors Inc. now owns 112 shares of the company’s stock valued at $33,000 after purchasing an additional 107 shares during the last quarter. CYBER HORNET ETFs LLC purchased a new stake in Molina Healthcare in the second quarter valued at approximately $45,000. MUFG Securities EMEA plc acquired a new stake in shares of Molina Healthcare in the second quarter valued at approximately $48,000. Zions Bancorporation National Association UT increased its holdings in shares of Molina Healthcare by 121.8% in the 2nd quarter. Zions Bancorporation National Association UT now owns 193 shares of the company’s stock valued at $57,000 after acquiring an additional 106 shares during the period. Finally, Bogart Wealth LLC acquired a new position in shares of Molina Healthcare in the 3rd quarter valued at $39,000. Institutional investors and hedge funds own 98.50% of the company’s stock.

Wall Street Analysts Forecast Growth

MOH has been the topic of several research reports. Wells Fargo & Company raised their price objective on shares of Molina Healthcare from $165.00 to $208.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 7th. Mizuho set a $220.00 price target on Molina Healthcare in a research report on Friday, January 9th. Wall Street Zen cut Molina Healthcare from a “hold” rating to a “sell” rating in a research report on Saturday, October 25th. Morgan Stanley set a $158.00 target price on Molina Healthcare in a research note on Friday, October 24th. Finally, Jefferies Financial Group set a $160.00 price target on Molina Healthcare in a research note on Tuesday, December 16th. Three analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, Molina Healthcare presently has a consensus rating of “Hold” and a consensus price target of $164.79.

Check Out Our Latest Analysis on MOH

Molina Healthcare Stock Up 6.7%

MOH opened at $135.20 on Monday. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.69 and a quick ratio of 1.69. The business has a 50 day simple moving average of $171.08 and a 200-day simple moving average of $169.48. The stock has a market capitalization of $6.96 billion, a P/E ratio of 15.79 and a beta of 0.49. Molina Healthcare, Inc has a 12 month low of $121.06 and a 12 month high of $359.97.

Molina Healthcare (NYSE:MOHGet Free Report) last released its quarterly earnings data on Thursday, February 5th. The company reported ($2.75) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.43 by ($3.18). Molina Healthcare had a return on equity of 13.60% and a net margin of 1.04%.The business had revenue of $11.38 billion during the quarter, compared to analysts’ expectations of $10.90 billion. During the same quarter in the previous year, the company posted $5.05 EPS. The company’s revenue was up 8.3% compared to the same quarter last year. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. On average, equities analysts anticipate that Molina Healthcare, Inc will post 24.4 earnings per share for the current fiscal year.

Insider Activity at Molina Healthcare

In other Molina Healthcare news, Director Richard M. Schapiro sold 357 shares of the company’s stock in a transaction dated Monday, November 24th. The shares were sold at an average price of $143.02, for a total transaction of $51,058.14. Following the transaction, the director directly owned 11,352 shares in the company, valued at approximately $1,623,563.04. This represents a 3.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 1.26% of the stock is owned by company insiders.

Molina Healthcare Profile

(Free Report)

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.

Featured Stories

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.